And it’s like the last 12 months to 14 months that really kind of ramped up. So, just sticking for me, I mean, Board and I agreed that I think with these important strategic transactions behind us, I just would thank Cameron for putting up with me for all this period of time, until we got these things done. And then I’d also say, it’s important. I talked about the return to normalcy, but I want to make sure we have a stable macroeconomic environment and really this is the first period since probably 2019 that we’ve had, do any kind of real stability, normalcy our businesses are operating at very good levels. So, I think the timing is right and I’ll quite really be sitting on a beach that . Darrin, if you’re ever in , just come visit me.
Darrin Peller: Thanks, Jeff. Well, congrats again. I guess my quick follow-up would just be on thinking about pricing in the industry, we’ve now seen – I know you talked a lot, Cameron, you just talked a little more about value-added services and mix and it being pretty tight, but we see now between Pfizer and just across the industry, these as well showing pricing changes. And so after having seen quite a bit of cost inflation for a couple of years, we would think there could be some opportunity on the price front. Any comment on that or any thoughts?
Cameron Bready: Yes, Darren. I think our perspective around pricing really hasn’t changed and the philosophy that we have has been pretty consistent for many years now. We try to price our services to reflect the level of value and capability that we’re bringing to the market, which we do think in many ways is differentiated from our competitors. Think we were very hard to try to optimize our pricing and have for again the past several years to make sure that we’re constantly looking at, sort of the price points and how we’re packaging a variety of different value-added services and capabilities we can bring along with obviously the pure payment acceptance solutions that we offer to the marketplace. So, our perspective is look, I think overall more people are being, I’d say, on the more aggressive side, perhaps for lack of a better term with their pricing strategies more recently.
I think that bodes well as it relates to the competitive landscape and particularly how we try to position our business over a long period of time. So, nothing unusual coming from us as a pricing matter. I would say, it’s more of the same, looking at portfolio optimization and pricing strategies again to try to reflect the value and service that we bring to the customer, but obviously in the backdrop with other people doing that makes it a little bit easier for those to stick. It is probably the point I would make into that.
Darrin Peller: Great. Nice job on the quarter guys. Congrats again. Thanks.
Jeff Sloan: Thanks, Darrin.
Cameron Bready : Thanks, Darrin.
Operator: Thank you. Your next question is coming from James Faucette from Morgan Stanley. Your line is now live.
James Faucette: Great. Thank you very much and want to add my congratulations to both, you, Jeff and Cameron. Wanted to follow-up on Darrin’s question there about timing and maybe Cameron with a few key things now accomplished and closed, how are you thinking about strategically next steps, especially given you’re still in very good capital position and is it still time to keep looking at doing other acquisitions or does your prioritization change to integration and incorporating everything that – the recent acquisitions, including EVO Payments brings?
